Frequency of Contrast-Induced Nephropathy in Type 2 DiabetesMellitus Patients Underwent Percutaneous Coronary Interventionfor Acute Coronary Syndrome


  • Author- Waqar Ahmad, Anas Sajjad, Farwa Abbas, Amna Riaz, Rae Hasnain Shehzad, Iqra Waheed


Objective: The purpose of this study was to determine the incidence of contrast-induced nephropathy in patients with type 2 diabetes mellitus who had percutaneous coronary intervention for acute coronary syndrome.


This descriptive study was undertaken in Department of Cardiology, Mayo Hospital, Lahore during July 2018 to January 2019. Total 165 patents fulfilling selection criteria were enrolled in the study. Then all patients underwent PCI. After that, patients were sent to cardiology wards and monitored for the next two days. Serum creatinine levels were measured after 48 hours of blood collection. If creatinine>25% from baseline, then CIN was labelled.


 The mean age of patients was 55.75±6.05 years. There were 125(75.8%) males and 40(24.2%) females. The mean duration of diabetes mellitus was 7.97±0.98 years. The mean duration of ACS was 10.84±5.95hours. There were 57(34.54%) patients who were diagnosed with CIN.


 The frequency of CIN in type 2 diabetes mellitus patients underwent PCI forACS was 34.54%.


Contrast-induced nephropathy, type 2 diabetes mellitus, percutaneous coronary intervention